| Dr Benjamin J Brill, DO | |
|
100 Hospital Rd Ste 3c, Leominster, MA 01453 | |
| (978) 534-6333 | |
| Not Available |
| Full Name | Dr Benjamin J Brill |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 100 Hospital Rd Ste 3c, Leominster, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609202555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 281101 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Health Alliance Home Health And Hospice | Leominster, MA | Home health agency |
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Heywood Hospital - | Gardner, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heywood Medical Group Inc. | 6901882836 | 82 |
| Longview Orthopaedic Center, Llc | 8628143120 | 6 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
All children are screened for a host of conditions at birth, such as Phenylketonuria (PKU), a genetic disorder that is passed by mutated genes from both parents to their offspring. PKU is rare, only affecting one in every 10,000 children in the U.S.; therefore, it is seldom studied.
A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers.
› Verified 1 days ago
| Entity Name | Henry Heywood Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205823879 PECOS PAC ID: 1658262605 Enrollment ID: O20040322000360 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
All children are screened for a host of conditions at birth, such as Phenylketonuria (PKU), a genetic disorder that is passed by mutated genes from both parents to their offspring. PKU is rare, only affecting one in every 10,000 children in the U.S.; therefore, it is seldom studied.
A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers.
› Verified 1 days ago
| Entity Name | Heywood Medical Group Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699762286 PECOS PAC ID: 6901882836 Enrollment ID: O20040629001351 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
All children are screened for a host of conditions at birth, such as Phenylketonuria (PKU), a genetic disorder that is passed by mutated genes from both parents to their offspring. PKU is rare, only affecting one in every 10,000 children in the U.S.; therefore, it is seldom studied.
A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers.
› Verified 1 days ago
| Entity Name | Athol Memorial Hospital Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336120047 PECOS PAC ID: 7911959846 Enrollment ID: O20050218000228 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
All children are screened for a host of conditions at birth, such as Phenylketonuria (PKU), a genetic disorder that is passed by mutated genes from both parents to their offspring. PKU is rare, only affecting one in every 10,000 children in the U.S.; therefore, it is seldom studied.
A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers.
› Verified 1 days ago
| Entity Name | Longview Orthopaedic Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306914593 PECOS PAC ID: 8628143120 Enrollment ID: O20080819000073 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
All children are screened for a host of conditions at birth, such as Phenylketonuria (PKU), a genetic disorder that is passed by mutated genes from both parents to their offspring. PKU is rare, only affecting one in every 10,000 children in the U.S.; therefore, it is seldom studied.
A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin J Brill, DO 100 Hospital Rd Ste 3c, Leominster, MA 01453-2253 Ph: (978) 534-6333 | Dr Benjamin J Brill, DO 100 Hospital Rd Ste 3c, Leominster, MA 01453 Ph: (978) 534-6333 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced results from a Phase 3 clinical study that showed the investigational compound dapagliflozin 10 mg demonstrated significant reductions in blood sugar levels (glycosylated hemoglobin levels, or HbA1c) compared with placebo at 24 weeks when either agent was added to existing sitagliptin therapy (with or without metformin) in adult patients with type 2 diabetes.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist - but the exact reasons for the cost increases are unclear.
All children are screened for a host of conditions at birth, such as Phenylketonuria (PKU), a genetic disorder that is passed by mutated genes from both parents to their offspring. PKU is rare, only affecting one in every 10,000 children in the U.S.; therefore, it is seldom studied.
A new study has uncovered a problem in pediatrics thought to be a major issue only in adult medicine: pressure ulcers.
› Verified 1 days ago
Kyle Patrick Lavery, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Rd, Leominster, MA 01453 Phone: 978-466-4220 Fax: 978-466-4240 | |
Dr. Kelton M Burbank, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Rd, Suite 3c, Leominster, MA 01453 Phone: 978-534-6333 Fax: 978-840-0866 | |
Dr. Marisa A Schmitt, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 100 Hospital Rd, Suite 3c, Leominster, MA 01453 Phone: 978-534-6333 Fax: 978-840-0866 | |
Hayden B. Rockson, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 100 Hospital Rd Ste 3c, Leominster, MA 01453 Phone: 978-534-6333 Fax: 978-840-0966 | |
Robert Francis Jones, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Rd, Suite 3c, Leominster, MA 01453 Phone: 978-534-6333 Fax: 978-840-0966 |